TECH - Bio-Techne Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TECH is currently covered by 8 analysts with an average price target of $70.13. This is a potential upside of $18.29 (35.28%) from yesterday's end of day stock price of $51.84.

Bio-Techne Corp's activity chart (see below) currently has 65 price targets and 77 ratings on display. The stock rating distribution of TECH is 73.68% BUY, 21.05% HOLD and 5.26% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.55% with an average time for these price targets to be met of 134.62 days.

Highest price target for TECH is $90, Lowest price target is $60, average price target is $81.17.

Most recent stock forecast was given by ROBERT WASSERMAN from BENCHMARK on 05-Jun-2025. First documented stock forecast 10-Nov-2016.

Split History since 2000:

12/4/00 2 for 1

Currently out of the existing stock ratings of TECH, 14 are a BUY (73.68%), 4 are a HOLD (21.05%), 1 are a SELL (5.26%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$75

$25.11 (50.33%)

$75

22 days ago
(05-Jun-2025)

0/6 (0%)

$26.69 (55.25%)

Hold

$60

$10.11 (20.26%)

$65

1 months 19 days ago
(08-May-2025)

5/6 (83.33%)

$10.22 (20.53%)

123

Buy

$80

2 months 18 days ago
(09-Apr-2025)

1/4 (25%)

$27.53 (52.47%)

191

Buy

$90

$40.11 (80.40%)

$88

4 months 21 days ago
(06-Feb-2025)

0/2 (0%)

$15.08 (20.13%)

Buy

$82

$32.11 (64.36%)

$85

1 years 2 months 9 days ago
(18-Apr-2024)

1/3 (33.33%)

$20.06 (32.39%)

26

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TECH (Bio-Techne Corp) average time for price targets to be met?

On average it took 134.62 days on average for the stock forecasts to be realized with a an average price target met ratio 57.55

Which analyst has the current highest performing score on TECH (Bio-Techne Corp) with a proven track record?

PATRICK DONNELLY

Which analyst has the most public recommendations on TECH (Bio-Techne Corp)?

Patrick Donnelly works at CITI and has 15465 price targets and 12220 ratings on TECH

Which analyst is the currently most bullish on TECH (Bio-Techne Corp)?

David Toung with highest potential upside - $70.93

Which analyst is the currently most reserved on TECH (Bio-Techne Corp)?

Paul Knight with lowest potential downside - -$0

Bio-Techne Corp in the News

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing

Kytopen and Bio-Techne announce partnership on an integrated cellular engineering workflow to expedite cell therapy manufacturing. The TcBuster™ system offers a fast and scalable method to integrate large, multigene cargos with high editing efficiency in a single vector, while Flowfect® continuous flow technology enables the gentle, high-efficiency processing of billions of cells in minutes. The...

Bio-Techne to Present at the BofA Securities 2025 Health Care Conference

MINNEAPOLIS, May 8, 2025 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 10:40 a.m. PDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne’s...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?